Generic competition and prices for azelastine-fluticasone nasal spray.

IF 7.2 2区医学 Q1 OTORHINOLARYNGOLOGY

International Forum of Allergy & Rhinology Pub Date : 2024-08-30 DOI:10.1002/alr.23443

Akash M Bhat, Zachary M Soler, Rodney J Schlosser, George A Scangas, Alan D Workman, Vinay K Rathi

引用次数: 0

Abstract

Key points: The original manufacturer of azelastine‒fluticasone (AZ‒FL) prevented generic availability until 2020 via patent enforcement. Following generic availability of AZ‒FL, Medicare utilization increased and spending decreased. Retail prices for generic AZ‒FL remain high due to markup by manufacturers and pharmacies.

查看原文本刊更多论文

阿折拉斯汀-氟替卡松鼻腔喷雾剂的仿制药竞争和价格。

要点：阿折拉斯汀-氟替卡松（AZ-FL）的原生产商通过专利实施阻止仿制药上市，直到 2020 年。仿制药 AZ-FL 上市后，医疗保险的使用率增加，支出减少。由于制造商和药店的加价行为，AZ-FL 非专利药的零售价格仍然居高不下。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

International Forum of Allergy & Rhinology OTORHINOLARYNGOLOGY-

CiteScore

11.70

自引率

10.90%

发文量

185

审稿时长

6-12 weeks

期刊介绍： International Forum of Allergy & Rhinologyis a peer-reviewed scientific journal, and the Official Journal of the American Rhinologic Society and the American Academy of Otolaryngic Allergy. International Forum of Allergy Rhinology provides a forum for clinical researchers, basic scientists, clinicians, and others to publish original research and explore controversies in the medical and surgical treatment of patients with otolaryngic allergy, rhinologic, and skull base conditions. The application of current research to the management of otolaryngic allergy, rhinologic, and skull base diseases and the need for further investigation will be highlighted.